 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
||||||||||||||||||||||||||
|
|
||||||||
|
|
||||||||||||||
|
|
||||||||||||||||||||
 |
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||
|
||||||
|
| 09 Nov. 2003 | U.S. Patent for Mindset's Alzheimer's Disease Vaccine Allowed | |
|
|
||
| 10 Sep. 2002 | Mindset is pleased to announce that Shalom Allenstein, B.Sc (Econ), ACA, CPA, has joined the company as Chief Financial Officer | |
|
|
||
| 22 July 2002 | Mindset and New York University Collaborate on Novel Vaccine Technology for Alzheimer’s Disease | |
|
|
||
| 10 June 2002 | U.S. Patent Reinforces Mindset’s Leadership in Alzheimer’s Disease Drug Discovery | |
|
|
||
| 31 Jan. 2002 | Nano-Technology for HIV Drugs, Self-Aware DNA and New Approaches to Alzheimer's at Bio-Tech Israel 2002 | |
|
|
||
| 20 Dec. 2001 | MPM Capital L.P. and Clal Biotechnology Industries Ltd. Co-Lead Investment in Alzheimer’s Disease Therapy Company – Mindset BioPharmaceuticals (USA) Inc. | |
|
|
||
| 11 Apr. 2001 | Proteome Sciences and Mindset combine expertise and receive grant to establish protein markers in major Alzheimer’s disease research programme | |
|
|
||
|
|
|
| Mindset BioPharmaceuticals Ltd. - 5 Kiryat
HaMada, Har Hotzvim - P.O.B. 45032 Jerusalem 91450 Tel: 972 2 5869539 - Fax: 972 2 5869586 - E-Mail: info@mindsetbiopharm.com Web: www.mindsetbiopharm.com | Legal Notice |